A detailed history of Twin Tree Management, LP transactions in Repligen Corp stock. As of the latest transaction made, Twin Tree Management, LP holds 27,200 shares of RGEN stock, worth $3.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,200
Previous 27,200 -0.0%
Holding current value
$3.88 Million
Previous $3.43 Million 18.06%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $946,340 - $1.2 Million
6,819 Added 86.37%
14,714 $2.34 Million
Q2 2023

Aug 11, 2023

SELL
$138.42 - $180.31 $1.61 Million - $2.1 Million
-11,639 Reduced 59.58%
7,895 $1.12 Million
Q1 2023

May 10, 2023

SELL
$154.26 - $198.1 $8.31 Million - $10.7 Million
-53,898 Reduced 73.4%
19,534 $3.29 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $1.54 Million - $2.09 Million
9,481 Added 14.83%
73,432 $12.4 Million
Q3 2022

Nov 10, 2022

BUY
$160.42 - $256.21 $10.3 Million - $16.4 Million
63,951 New
63,951 $12 Million
Q2 2022

Aug 11, 2022

SELL
$140.68 - $188.02 $2.66 Million - $3.56 Million
-18,942 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$161.19 - $257.96 $2.06 Million - $3.3 Million
12,787 Added 207.75%
18,942 $3.56 Million
Q4 2021

Feb 10, 2022

BUY
$247.59 - $304.47 $1.52 Million - $1.87 Million
6,155 New
6,155 $1.63 Million
Q2 2021

Aug 12, 2021

SELL
$165.87 - $220.95 $299,229 - $398,593
-1,804 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $325,387 - $408,173
1,804 New
1,804 $351,000
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $810,648 - $1.05 Million
-6,617 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$94.33 - $140.48 $556,735 - $829,112
5,902 Added 825.45%
6,617 $818,000
Q1 2020

May 13, 2020

BUY
$84.96 - $109.14 $60,746 - $78,035
715 New
715 $69,000
Q2 2019

Aug 12, 2019

SELL
$54.2 - $85.95 $7,100 - $11,259
-131 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$49.45 - $62.8 $6,477 - $8,226
131 New
131 $8,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.